LEUKOS BIOTECH S L has a total of 12 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PRIMUS PHARMACEUTICALS INC, Shionogi Inc and LIU BAOSHUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tesson Nicolas | 7 |
#2 | Llaudet Carles Enrique | 7 |
#3 | Muñoz Risueño Ruth | 4 |
#4 | Lara Castillo Mari Carmen | 4 |
#5 | Etxabe Alberdi Amaia | 4 |
#6 | Trilla Castaño Montserrat | 4 |
#7 | Trilla Castano Montserrat | 3 |
#8 | Enrique Llaudet Carles | 1 |
#9 | Montserrat Trilla Castaño | 1 |
#10 | Nicolas Tesson | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019141673A1 | Apomorphine·palmitic acid cocrystal solid particle crystalline form | |
EP3348266A1 | Combination therapy for treating cancer |